| Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells R Duwa, A Banstola, F Emami, JH Jeong, S Lee, S Yook Journal of drug delivery science and technology 60, 101928, 2020 | 46 | 2020 |
| Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme R Duwa, F Emami, S Lee, JH Jeong, S Yook Journal of Industrial and Engineering Chemistry 79, 261-273, 2019 | 37 | 2019 |
| Enhancement of blood–brain barrier penetration and the neuroprotective effect of resveratrol N Katila, R Duwa, S Bhurtel, S Khanal, S Maharjan, JH Jeong, S Lee, ... Journal of Controlled Release 346, 1-19, 2022 | 36 | 2022 |
| Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles in … A Banstola, R Duwa, F Emami, JH Jeong, S Yook Molecular Pharmaceutics 17 (11), 4386-4400, 2020 | 29 | 2020 |
| Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease R Duwa, JH Jeong, S Yook Journal of Pharmaceutical Investigation 51, 465-481, 2021 | 21 | 2021 |
| T-cell engaging poly (lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer R Duwa, RH Pokhrel, A Banstola, M Pandit, P Shrestha, JH Jeong, ... Biomaterials 291, 121911, 2022 | 17 | 2022 |
| Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction R Duwa, JH Jeong, S Yook Journal of Industrial and Engineering Chemistry 94, 62-77, 2021 | 11 | 2021 |
| Reactive oxygen species‐responsive dual‐targeted nanosystem promoted immunogenic cell death against breast cancer A Banstola, M Pandit, R Duwa, JH Chang, JH Jeong, S Yook Bioengineering & Translational Medicine 8 (5), e10379, 2023 | 6 | 2023 |
| Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy F Emami, R Duwa, A Banstola, SM Woo, TK Kwon, S Yook Biomedicine & Pharmacotherapy 165, 115023, 2023 | 5 | 2023 |
| Triple-negative breast cancer treatment meets nanoparticles: Current status and future direction MK Shokooh, F Emami, R Duwa, JH Jeong, S Yook Journal of Drug Delivery Science and Technology 71, 103274, 2022 | 4 | 2022 |
| Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy BTN Dang, R Duwa, S Lee, TK Kwon, JH Chang, JH Jeong, S Yook Journal of Controlled Release 372, 587-608, 2024 | | 2024 |
| Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy R Duwa, J Choi, P Shrestha, TTK Nguyen, LD Bastatas, Y Gwon, S Park, ... Chemical Engineering Journal, 153128, 2024 | | 2024 |
| Enhanced Anticancer Efficacy of TRAIL-Conjugated and Odanacatib-Loaded PLGA Nanoparticles in TRAIL Resistant Cancer TTK Nguyen, SM Woo, SU Seo, A Banstola, H Kim, R Duwa, V An, ... Available at SSRN 4743115, 0 | | |
Jee-Heon JeongDepartment of Precision Medicine, School of Medicine, Sungkyunkwan University在 g.skku.edu 的电子邮件经过验证
